This page shows the Early Day Motions where the main subject matter was HIV/AIDS from the current Parliamentary session which began in November 2006.

EDM 2171

IMPROVING SUPPORT FOR CHILDREN AFFECTED BY AIDS      (22/10/2007) 

Keeble, Sally

That this House welcomes the Government's consultation process for its new strategy to tackle HIV and AIDS across the world; notes with concern the 15 million children orphaned by AIDS worldwide; calls on the Government in its new HIV and AIDS strategy (2008-2011) to continue to earmark at least 10 per cent. of all its HIV and AIDS funding for children affected by AIDS, support national governments in delivering comprehensive and integrated services to prevent mother to child transmission, place strong emphasis on the development of infant diagnostics adaptable to resource limited settings, ensure all children have full access to antiretroviral therapy and treatment for opportunistic infections by including children both in national treatment targets and when monitoring progress towards universal access and take specific steps to strengthen government departments responsible for the social welfare of children, as well as providing long-term funding and support to civil society organisations working with children affected by AIDS.

EDM 1835

HEALTH WORKERS IN AFRICA        (04/07/2007) 

George, Andrew

That this House notes the impact of the continuing health worker crisis in Africa; further notes that diseases such as HIV/AIDS, TB and malaria cannot be tackled unless immediate action is taken to build the numbers and capacity of health workers; welcomes the UK Government's recognition of the shortage of trained and motivated health workers in the Department for International Development's strategy Working together for better health, and its commitment to help countries solve staffing crises and develop long-term health plans; and believes that it is necessary to provide support to African governments to match the skills of workers to local needs by enhancing the essential contribution made by health workers and community health workers in providing preventative care and treatment at the local community level where it is most needed.

EDM 1586

HIV PREVENTION SERVICES IN LONDON       (04/06/2007) 

Abbott, Diane

That this House recognises that, as reported by the Health Protection Agency, the current provision for HIV prevention in London has been having a positive impact; notes that this has been achieved in the context of a steep rise in infection rates outside London; further notes with concern that the current provisions for HIV prevention are to be reorganised and replaced by a new system which has been criticised by many organisations working within the HIV sector; and thus calls upon the Government to take on board the criticisms made during the consultation process to ensure that any reorganisation of services builds on the positive work already done in this area, as well as the support of the community.

EDM 1556

ACCESS TO TREATMENT FOR HIV      (23/05/2007) 

Gerrard, Neil

That this House notes that there is a clear contradiction between the UK's policy aim of universal access to treatment for all those who need it by 2010 and the deportation of people living with HIV who are on treatment to countries where treatment is not readily available or affordable; further notes that the withdrawal of treatment increases the body's vulnerability to opportunistic infection and will result in drastically shortened life expectancy; and welcomes the launch of the African HIV Policy Network's campaign calling on the Government to allow HIV positive people on HIV treatment to stay in the United Kingdom until they are able to return home when access to antiretroviral treatments becomes more widely available.

EDM 1120

PNEUMOCOCCAL DISEASE PREVENTION IN THE DEVELOPING WORLD      (13/03/2007)

Turner, Desmond

That this House notes with grave concern that according to the World Health Organisation pneumococcal pneumonia and meningitis are responsible for up to 1.6 million deaths each year of which one million are children; further notes that 90 per cent. of pneumococcal pneumonia deaths occur in the developing world and that children with HIV/AIDS are up to 40 times more likely to contract pneumococcal disease; further notes that many of these deaths could be prevented with the use of a vaccine; welcomes the commitment by HM Treasury and the Department for International Development to support the pilot Advanced Market Commitment (AMC) for pneumococcal vaccines, which could save the lives of up to 5.4 million children by 2030; notes the contribution which this programme will make towards the UK's commitment to meeting the United Nations' Millennium Development Goal 4, `to reduce by two thirds the mortality rate among children under five by 2015'; further welcomes the formation of the All-Party Parliamentary Group on Pneumococcal Disease Prevention in the Developing World in response to the urgent need to improve child survival and as a forum for raising awareness among policymakers nationally, across Europe and around the world about the disease, its prevention through vaccination and international efforts to ensure sustainable financing; and hopes that the pneumococcal vaccine pilot AMC will pave the way for new vaccines against other childhood diseases such as malaria

EDM 1053

HIV AND PERCEIVED OR ASSOCIATIVE DISABILITY DISCRIMINATION     (06/03/2007) 

Moffatt, Laura

That this House notes that legal protection for people living with HIV from the effects of HIV prejudice and discrimination has been greatly improved by the extension of the Disability Discrimination Act to cover conditions such as HIV effectively from the point of diagnosis; notes that people who are not themselves HIV positive can face discrimination because of an association with someone who is HIV positive or because they are perceived to be HIV positive; further notes that this could include partners of people with HIV, family members and carers, or just people who belong to groups amongst whom HIV is of higher prevalence, such as gay men and recent African migrants; further notes that the European Court of Justice has been asked to determine whether the European Framework Directive on Equal Treatment in Employment prohibits discrimination on grounds of association with a disabled person following a reference from the Employment Tribunal and the appeal decision of the EAT in the case of Attridge Law and S Law v. Coleman (UKEAT/0417/06/DM); congratulates Ireland, Sweden, the Netherlands, Germany, Malta, Denmark, Portugal and Spain for introducing legislation to protect people who experience discrimination on the basis of association or perception of disability; and calls on the Government to follow suit and make explicit provisions prohibiting discrimination on the basis of association or perception of disability in future legislation.

EDM 753

AFFORDABLE MEDICINES FOR THE DEVELOPING WORLD     (25/01/2007) 

Featherstone, Lynne

That this House notes with concern that the European company Novartis, the makers of the anti-leukaemia drug Glivec, has brought a case against the Indian government to prevent manufacturers of generic medicines from producing low-cost copies of that drug; further notes that the generic medicines produced in India are essential treatments for many people in the developing world, especially those living with HIV/AIDS, and that millions of people rely on drugs produced in India for affordable medicines; and therefore urges Novartis to withdraw its action.

EDM 649

CHILDREN AT THE VENERABLE BEDE SCHOOL        (16/01/2007)

Kemp, Fraser

That this House welcomes the efforts of the students at the Venerable Bede Church of England School in Ryhope, Sunderland, who are helping orphan children in the AIDS-affected nation of Lesotho; also welcomes the fact-finding mission by deputy head teachers Marie Lister and Jane Ackroyd, who flew to meet the Reverend Mavis Mochokocho in the capital Maseru at the Salvation Orphanage, which cares for HIV-affected orphans; congratulates the Ryhope pupils for their commitment to install solar panels at the orphanage; and wishes the Ryhope pupils all the best in their efforts to help the HIV and AIDS-affected orphans in Lesotho.

EDM 496

TAINTED BLOOD CAMPAIGN       (13/12/2006)

Jenny Willott

That this House notes that 4,800 British haemophiliacs and many others were infected with hepatitis C through their NHS treatment, with 1,200 of those also infected with HIV; further notes that over 800 people have already died from AIDS with hundreds more having died from hepatitis C; further notes the destruction in the late 1980s and early 1990s of many documents relating to this issue that were being held by the Department of Health and that could have aided the Self-Sufficiency in Blood Products report into this affair in early 2006; is pleased that many of these documents have been discovered since by Blackett, Heart and Pratt Solicitors and have now been returned to the Department of Health for independent legal examination; further notes that a number of boxes of relevant documents have also been discovered since by the Department of Health; is concerned that these have not yet been assigned for independent legal examination; supports the Tainted Blood Campaign; believes that with the discovery of these documents there is now an ideal opportunity to get to the bottom of this issue by launching a full, independent public inquiry into contaminated blood products and to provide an official explanation to those who have fallen victim directly or indirectly to HIV and hepatitis C through contaminated blood products; and therefore urges the Government to respond positively to this campaign so that, after 20 years, justice can be done finally.

EDM 411

BLUE PETER SHOE BIZ APPEAL       (05/12/2006)

Shailesh Vara

That this House welcomes the launch of the BBC's 45th Blue Peter annual appeal; congratulates Blue Peter on running the Shoe Biz Appeal, which is asking children across the UK to collect shoes to be recycled to raise money for children orphaned by AIDS in Malawi, where somebody dies of an AIDS-related illness every eight minutes and as a result there are now more than 600,000 orphans; notes that Blue Peter viewers are being asked to collect as many of the nation's unwanted shoes as possible; and calls upon all hon. Members to join in and recycle their unwanted shoes in aid of the appeal.

EDM 368

WORLD AIDS DAY 2006       (30/11/2006)

John Barrett

That this House fully supports World Aids Day on 1st December, which provides an opportunity for people worldwide to unite in the fight against HIV and AIDS; recognises that more people were infected in 2006 than in any previous year with 40 million people worldwide now living with HIV, of which 2.3 million are children; notes that children and young people are among the most vulnerable and unsupported individuals marginalised by the AIDS pandemic; is deeply concerned that fewer than five per cent. of children are receiving life-saving anti-retroviral treatment; recognises that the international community has an obligation to these children to uphold the promises and commitments to universal access to HIV prevention treatment and care by 2010; further notes that in the UK, more than 60,000 people are living with HIV and more than 7,000 more are diagnosed every year; and calls on the Government to commit the necessary resources and to use its international influence to ensure that the Millennium Development Goals on HIV and AIDS are met, and that sufficient resources are committed to care for those in the UK living with HIV.

EDM 270a1

USE OF PRIMATES IN EXPERIMENTS       (27/11/2006)

Evan Harris

- leave out from `the' to end and add `tightly regulated use of non-human primates is currently still a vital and necessary tool in developing new treatments and vaccinations for major human diseases such as Alzheimer's, Parkinson's disease, HIV/AIDS, TB and malaria and that such use of animals cannot yet be completely replaced by alternatives such as functional magnetic resonance imaging, micro-dosing, computer-modelling or tissue cell culture; accepts that UK animal welfare standards are high and that primate research is only licensed when there is no alternative; calls for support for the 3Rs (refinement, reduction and replacement) to improve animal welfare, minimize the number of animals used and find alternatives to animals; and urges the EU institutions and the member states to pay special attention to the use of non-human primates in experiments in the revision process of directive 86/609.'.

EDM 117

NYUMBANI AIDS ORPHANAGE       (20/11/2006)

Timothy Farron

That this House notes with regret that 68 million people are predicted to die because of AIDS in the 45 most affected African countries by 2020 and that there will be an estimated 40 million AIDS orphans; commends the work of charities such as the Nyumbani Orphanage in Nairobi, which provides care for AIDS orphans; and further commends Nyumbani's community-based outreach programme, Lea Toto, which helps children who have limited family support, and the pioneering work at the Nyumbani Village, which will provide a home for over 1,000 AIDS-affected orphans and their grandparents.

EDM 112

HIV AND PREGNANT WOMEN       (15/11/2006)

Paul Burstow

That this House notes with concern that not all HIV positive women in the UK are entitled to free treatment to prevent mother to baby transmission of HIV; recognises that guidance from the Department of Health clearly states that, because of the risks to both mother and baby, maternity services should always be considered to be immediately necessary and never withheld; further recognises that many women who need treatment are not aware of their entitlement and that fears about the cost of treatment means that some do not come forward or come forward too late for the treatment to be fully effective; acknowledges that there is also continuing widespread confusion within the NHS about what treatment women are entitled to; and calls on the Government to amend the 1989 Charges to Overseas Visitors Regulations to include HIV treatment alongside all other sexually transmitted infections which are currently exempt from charges, and to ensure all women are given free HIV treatment to maintain their health and enable them to survive to care for their child, regardless of their immigration status.

EDM 109

HIV TREATMENT AND NHS PRESCRIPTION CHARGES       (15/11/2006)

Paul Burstow

That this House notes that the regulations specifying conditions which qualify for prescription charge exemptions have not changed since 1968, and remain a significant barrier to the health care and quality of life of patients living with HIV; recognises that living with HIV, an infection first diagnosed 14 years after this legislation was introduced, can cause considerable physical and financial hardship; and calls on the Government to fulfil the commitment it made whilst in Opposition finally to review the list of conditions currently exempt from prescription charges, with a view to adding HIV to the list.

EDM 107

UNIVERSAL ACCESS TO HIV TREATMENT BY 2010 TARGET       (15/11/2006)

Neil Gerrard

That this House welcomes the UK Government's role in 2005 in establishing a global commitment to achieving universal access to HIV prevention, treatment and care by 2010; believes that keeping this promise requires a G8 funding plan fully to finance the global effort, investment in strong health systems, and genuinely affordable essential medicines; recognises that generic versions of essential medicines are an effective and necessary way to reduce the prices of key drugs; notes, however, that intellectual property rights remain a key barrier to the production and export of generic versions; and believes strongly that the UK Government should show international leadership, including at the 2007 G8 Summit, to improve access to generic medicines by proactively supporting the full use of TRIPS flexibilities, working to simplify mechanisms for producing and exporting key drugs and opposing conditions in bilateral trade agreements which undermine accesss to treatment.

EDM 26

HIV PREVENTION       (15/11/2006)

Laura Moffatt

That this House notes that levels of HIV infection are rising globally and over 38 million people worldwide are living with HIV, with women in developing countries disproportionately affected; acknowledges that existing HIV prevention methods help to reduce the risk of HIV transmission and acquisition and should be made available urgently to those who need them, but that existing prevention methods are not enough, particularly for women, due to a combination of biological, social and cultural factors; notes that new prevention technologies such as microbicides and vaccines are designed to complement current prevention efforts and could offer protection from HIV and increase the effectiveness of HIV prevention efforts, and will ultimately benefit women and men all over the world, in the UK as well as countries with a high HIV prevalence; acknowledges that progress has been made in the search for new prevention technologies such as microbicides and vaccines but that challenges remain; welcomes the UK's contribution to the research and development of microbicides and vaccines; and calls upon the Government to use its influence to urge the international community to recognise the importance of investing in new technologies as a vital part of the comprehensive response required to tackle effectively HIV and AIDS.

Parliament Page                Home Page